Westport Innovations Inc. (NASDAQ:WPRT) belongs to Consumer Goods sector. Its weekly performance is 7.96%. On last trading day company shares ended up $4.88. Westport Innovations Inc. (NASDAQ:WPRT) distance from 50-day simple moving average (SMA50) is -6.72%. Westport Innovations Inc., (NASDAQ:WPRT) has announced that the company will offer dedicated, liquid propane systems for 2016 Ford 5.0L F-150 trucks. This new liquid propane system will be offered in addition to Westport’s compressed natural gas (CNG) package for 2016 Ford F-150 trucks.
6D Global Technologies, Inc. (NASDAQ:SIXD) shares moved down -27.84% in last trading session and ended the day at $5.34. SIXD Gross Margin is 40.50%. 6D Global Technologies, Inc. (NASDAQ:SIXD) quarterly performance is -38.76%. 6D Global Technologies, Inc. (NASDAQ:SIXD), announced that the Company was added as a member of four Russell indexes including the Russell 2000(R), Russell 3000(R), Russell Global, and Russell Microcap(R) after the markets closed on June 26 as part of Russell Investment’s quarterly additions of select initial public offering (IPO) companies.
On 14 July, Deere & Company (NYSE:DE) shares moved up 0.14% and was closed at $96.40. DE EPS growth in last 5 year was 33.20%. Deere & Company (NYSE:DE) year to date (YTD) performance is 10.42%. John Deere will continue as a title sponsor of professional golf through 2023 as a result of a seven-year extension announced on 7 July by Deere & Company (NYSE:DE), the PGA TOUR and the John Deere Classic. The agreement includes sponsorship of the John Deere Classic and multiple designations for John Deere in the TOUR’s Official Marketing Partner program.
Bioanalytical Systems Inc. (NASDAQ:BASI) ended the last trading day at $1.93. Company weekly volatility is calculated as 2.88% and price to cash ratio as 31.07. Bioanalytical Systems Inc. (NASDAQ:BASI) showed a weekly performance of 2.11%. Bioanalytical Systems, Inc. (NASDAQ:BASI) has entered into an agreement with PDS Life Sciences (PDS) to fully upgrade its laboratory information management system (LIMS) to Ascentos™. The new Ascentos software represents the next generation of preclinical research LIMS and is a fully integrated software solution that includes toxicology, clinical pathology, toxicokinetics and pathology modules that streamline data management and reporting.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) shares advanced 2.27% in last trading session and ended the day at $1.35. PPHM Gross Margin is 38.50% and its return on assets is -61.20%. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) quarterly performance is -6.25%.Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.31 million versus the consensus estimate of $6.42 million.